Matthew Falagas MD, MSc, DSc

Falagas ME, Bliziotis I, Kondilis B, Papastamataki P, Zouglakis G, Soteriades E. Eighteen years of research on AIDS: contribution of and collaborations between different world regions. 16^th ECCMID ,Nice, France, April 2006.

Kofterides D, Falagas ME, Kavvadia P, Mantadakis E, Bliziotis I, Saloustros E, Maraki S, Samonis G. Morganella morganii infections in a general tertiary hospital.16^th ECCMID ,Nice, France, April 2006.

Kofteridis D, Falagas ME, Kasiakou S, Roditakis G, Alegakis D, Samonis G. Hospital-acquired multidrug resistant Gram-negative infections: Clinical features, treatment and outcome. 45^th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December, 2005.

Michalopoulos A, Falagas ME, Rellos K, Papadimitriou L, Geroulanos S, Kotsis V, Karatza D, Prapas S. Is cardiopulmonary bypass a risk factor for ARDS in patients undergoing CABG surgery? 18^thAnnual Congress of the European Society of Intensive Care Medicine (ESICM), Amsterdam, Netherlands, September 2005.

Michalopoulos A, Bliziotis I, Rizos M, Rellos K, Dimitriadou E, Boursinos V, Falagas ME. Worldwide research productivity in Critical Care. 18^thAnnual ESICM, Amsterdam, Netherlands, September 2005.

Michalopoulos A, Vardakas K, Samonis G, Nikita D, Soteriades E, Rellos K, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical ICU patients: a meta-analysis. 18^thAnnual ESICM, Amsterdam, Netherlands, September 2005.

Michalopoulos A, Prapas S, Geroulanos S, Rellos K, Rizos M, Nikita D, Georgoulias G, Falagas ME. Candidemia in patients undergoing CABG surgery with and without cardiopulmonary bypass. 18^thAnnual ESICM, Amsterdam, Netherlands, September 2005.

Rellos K, Falagas ME, Vardakas K, Sermaides G, Fotakis D, Papacharalabous V, Michalopoulos A. Outcome of critically “oldest old” patients (age ³ 90 years) admitted to the ICU. 18^thAnnual ESICM , Amsterdam, Netherlands, September 2005.

Falagas ME, Rizos M, Bliziotis I, Kasiakou SK, Michalopoulos A. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. 15^th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark, April 2005.

Bliziotis I, Peppas G, Rafailidis P, Vergidis PI, Kapaskelis A, Papastamataki PA, Falagas ME. Peripheral T-cell lymphoma masquerading as cellulitis. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Falagas ME, Bliziotis I, Mavrogenis A, Antoniou D, Papagelopoulos PJ. Spondylodiscitis after facet joint steroid injection. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Kasiakou SK, Rosmarakis E, Peppas G, Kapaskelis A, Sergounioti A, Falagas ME. Regression of skin lesions of Kyrle’s disease with clyndamycin: implications for an infectious component in the aetiology of the disease. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Kasiakou SK, Sermaides G, Michalopoulos A, Soteriades E, Falagas ME. Continuous versus intermittent administration of antibiotics: a meta-analysis of randomised controlled trials. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Kasiakou SK, Michalopoulos A, Rosmarakis E, Vergidis PI, Falagas ME. Cure of multidrug-resistant (MDR) Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Vardakas K, Soteriades E, Chrysanthopoulou S, Papagelopoulos PJ, Falagas ME. Perioperative anti-infective prophylaxis with teicoplanin or second generation cephalosporins in vascular and orthopaedic surgery involving prosthetic material: a meta-analysis of randomised controlled trials. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Bliziotis I, Samonis G, Vardakas K, Chrysanthopoulou S, Falagas ME. Effect of aminoglycoside/beta-lactam combination therapy versus beta lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomised controlled trials. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Bliziotis I, Michalopoulos A, Kasiakou SK, Samonis G, Christodoulou C, Chrysanthopoulou S, Falagas ME. Ciprofloxacin versus an aminoglycoside as combination therapy to a beta lactam for the treatment of febrile neutropenia: a meta-analysis of randomised controlled trials. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Bliziotis I, Paraschakis K, Vergidis PI, Karavasiou AI, Kapaskelis A, Falagas ME. Worldwide trends in quality of published articles in the field of Infectious Diseases. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Kasiakou SK, Fragoulis K, Tzagarakis G, Mistidis P, Kapaskelis A, Falagas ME. Cure of multidrug-resistant Acinetobacter baumannii prosthetic material-related orthopaedic infections with intravenous colistin. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Kasiakou SK, Rafailidis P, Liaropoulos K, Bliziotis I, Chelvatzoglou F, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intravenrticular colistin. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis A, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Kasiakou SK, Michalopoulos A, Soteriades E, Samonis G, Sermaides G, Falagas ME. Intravenous colistin for treatment of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Vergidis PI, Karavasiou AI, Paraschakis K, Bliziotis I, Papastamataki PA, Falagas ME. A bibliometric analysis of worldwide trends in research productivity in Microbiology. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Rosmarakis E, Vergidis PI, Kapaskelis A, Paraschakis K, Falagas ME. From conference abstract to full paper: differences between data resented in conferences and journals. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Falagas ME, Rizos M, Tsiodras S, Betsou A, Foukas P, Michalopoulos A. Usual interstitial pneumonia associated with cytomegalovirus infection after percutaneous transluminal coronary angioplasty. 15^th ECCMID, Copenhagen, Denmark, April 2005.

Rellos K, Georgoulias G, Karatza DC, Mastora Z, Boursinos V, Falagas ME, Michalopoulos A. Bacteraemia in Intensive Care Unit patients of a new general hospital. 7^th German Interdisciplinary Conference of Intensive Care Medicine, Hamburg, Germany, December 2004.

Falagas ME, Tsiodras S, Rellos K, MentzelopoulosS, Kasiakou S, Michalopoulos A. Effectiveness and safety of colistin treatment in patients with ICU-acquired infections due to multiresistant gram-negative bacteria: the renaissance of an old antibiotic. 42^nd Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, Massachusetts, September 2004.

Kasiakou SK, Kapaskelis AM, Paraschakis K, Chelvatzoglou FC, Sergounioti AE, Falagas ME. Continuous versus intermittent intravenous administration of antibiotics: a systematic review of clinical trials. 42^nd Annual Meeting of IDSA, Boston, Massachusetts, September 2004.

Barinaga JL, Falagas ME, Hadley S, Nasraway SA, Selker HP, Snydman DR. Systemic antifungal forprophylaxis of invasive Candida infections in surgical intensive care unit patients. 41^st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.

Avramopoulos I, Gatsiou C, Nikolidaki C, Feloukas T, Geromeriati K, Vakalis N, Achimastos A, Nasioulas G, Falagas ME. Streptococcus agalactiae infections in non-pregnant adults: Single center experience of a growing clinical problem. 11^th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Istanbul, Turkey, April 2001.

Avramopoulos I, Vakalis N, Sapkas G, Christopoulou M, Xinotroulas I, Nikolidaki C, Achimastos A, Falagas ME. Multidrug-resistant tuberculous spondylodiscitis: Growing evidence for the need of aggressive management of spondylodiscitis and drug susceptibility testing of Mycobacterium tubeculosis isolates. 11^th ECCMID, Istanbul, Turkey, April 2001.

Falagas ME, Papadimitropoulos V. Vaccination against typhoid fever in travelers: a cost-effectiveness approach. 39^th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, September 1999.

Falagas ME, Kosmopoulou O, Christodoulou C, Skarlos D. Treatment of neutropenic patients with fever in an outpatient setting. 21^st International Congress of Chemotherapy (ICC), Birmingham, England, July 1999.

Snydman DR, Falagas ME, Freeman R, Avery R. Cytomegalovirus immune globulin plus intravenous ganciclovir to prevent primary cytomegalovirus disease in liver transplants. 17h world congress of the Transplantation Society, Montreal, Canada, July 1998.

DesJardin J, Falagas ME, McDermott L, Snydman DR. In vitro synergy between trovafloxacin or ciprofloxacin and cefoperazone, ceftazidime, ticarcillin-clavulanic acid, or trimethoprim-sulfamethoxazole against Stenotrophomonas maltophilia. 8th International Congress of the International Infectious Diseases Society, Boston, Massachusetts, May 1998.

Giatras I, Falagas ME, Supran S, Freeman R, O’Connor K, Bradley J, Snydman DR, Delmonico FL. Outcome of transplantation of organs procured from bacteremic or fungemic donors. 24th Annual meeting of the American Society of Transplant Surgeons (ASTS), Chicago, Illinois, May 1998.

Falagas ME, Paya C, Ruthazer R, Badley A, Patel R, Wiesner R, Griffith J, Freeman R, Rohrer R, Snydman DR. Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: A derivation and validation cohort analysis. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, Canada, September 1997.

Falagas ME, MacDermott L, Snydman DR. The effect of pH on the in vitro susceptibility of Bacteroides fragilis group. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, Canada, September 1997.

DesJardin JA, Falagas ME, Warrose D, Ruthazer R, Snydman DR. Utilization of indwelling central venous catheters for obtaining blood cultures in hospitalized oncology patients: service or disservice. 37th ICAAC, Toronto, Canada, September 1997.

DesJardin JA, Falagas ME, Gibbons L, Levy S, Ablashi DV, Werner B, Snydman DR. Human herpes virus 6 (HHV-6) infection is associated with development of primary cytomegalovirus infection and disease in kidney transplantation. 37th ICAAC, Toronto, Canada, September 1997.

Falagas ME, Arbo M, Ruthazer R, Griffith J, Freeman R, Rohrer R, Lewis D, Snydman DR. The impact of cytomegalovirus on cost and first post-transplant year hospital length of stay among liver transplant recipients. 16th annual meeting of the American Society of Transplant Physicians (ASTP), Chicago, Illinois, May 1997.

Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG, Freeman R, Rohrer R, and the Boston Center for Liver Transplantation CMVIG study group Cytomegalovirus Immune Globulin (CMVIG) is associated with improved one-year and long-term survival in orthotopic liver transplant recipients. 16th annual meeting of the American Society of Transplant Physicians (ASTP), Abstract # 254, Chicago, Illinois, May 1997.

Engels E, Falagas ME, Schmidt C, Lau J, Bennish M. Efficacy of typhoid fever vaccines: A meta-analysis. BioMedicine 1997, Tri-Society meeting , Washington, DC, May 1997.

Falagas ME, Soteriades E, Mantzoros C. Greek biomedical scientists in diaspora: a national resource. Foundation of a database of Greek biomedical scientists in diaspora. 4th World Biomedical Conference of the Hellenic Diaspora , Nicosia, Cyprus, October 1996.

Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, and the Boston Center for Liver Transplantation CMVIG study group. Primary cytomegalovirus infection in liver transplantation: Comparison between donor and transfusion transmitted infection. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, Louisiana, September 1996.

Falagas ME, Snydman DR, Ruthazer R, Werner BG, Griffith J, and the Boston Center for Liver Transplantation CMVIG study group. Lack of value of surveillance blood, urine, and throat cytomegalovirus cultures in predicting cytomegalovirus disease in liver transplant recipients. 36^thICAAC , New Orleans, Louisiana, September 1996.

McGrath D, Falagas ME, Rohrer R, Freeman R, Snydman DR. Adenoviral infections in adult orthotopic liver transplant recipients: Prevalence and clinical significance. 36th ICAAC, New Orleans, Louisiana, September 1996.

Falagas ME, Walker AM, Jick H, Ruthazer R, Griffith J, Snydman DR. Cancer incidence after metronidazole use: A matched metronidazole user/non-user study of 60,054 subjects. 36th ICAAC , New Orleans, Louisiana, September 1996.

Falagas ME, Barefoot L, Griffith J, Ruthazer R, Snydman DR. Risk factors for clinical failure of antibiotic therapy in patients with intra-abdominal or skin/soft tissue infections treated with cefotetan, cefoxitin, or ampicillin/sulbactam monotherapy: A retrospective controlled study. 1st European Congress of Chemotherapy , Glasgow, Scotland, May 1996.

Falagas ME, Snydman DR, Griffith J, Werner BG, Freeman R, Rohrer R, and the Boston Center for Liver Transplantation CMVIG study group. Predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. 35^th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, September 1995.

Falagas ME, Snydman DR, Griffith J, Werner BG, and the Boston Center for Liver Transplantation CMVIG study group. Cytomegalovirus exposure from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. 35th ICAAC , San Francisco, California, September 1995.

Pereira BJG, King AJ, Falagas ME, Shapiro L, Strom JA, Dinarello CA. Plasma cytokine levels in undialyzed chronic renal failure, CAPD, and hemodialysis patients reflect residual renal function. 12^th International Congress of Nephrology, Jerusalem, Israel, June 1993.

REFERENCES

1. Sherwood Gorbach, MD

Professor of Medicine, Family Medicine, and Community Health

Tufts University School of Medicine

136 Harrison Avenue, Boston, Massachusetts 02111

Tel: +1-617-636-5811, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

2. John Harrington, MD

Past Dean, Tufts University School of Medicine

145 Harrison Avenue, Boston, Massachusetts 02111

Tel: +1-617-636-6800, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

3. Gerald Keusch, MD, PhD

Professor of Medicine, Boston University School of Medicine

Director, International Health Center

715 Albany Street, Boston, Massachusetts

Tel: +1-617-638-5234, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

4. David Snydman, MD

Professor of Medicine and Pathology, Tufts University School of Medicine

Chief, Division of Infectious Diseases, New England Medical Center

750 Washington Street, Box 238, Boston, Massachusetts 02111

Tel: +1-617-636-5788, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

5. Dimitris Trichopoulos, MD, DSc

Vincent L. Gregory Professor of Cancer Prevention,

Department of Epidemiology, Harvard School of Public Health

Emeritus Professor of Epidemiology, Athens University School of Medicine

75 Mikras Asias Street, Athens, Greece

Tel: +30-210-746-2012, e-mail: dimitri@ hsph.harvard.edu

6. Alexander Walker, MD, DPH

Adjunct Professor of Epidemiology, Harvard University

667 Huntington Avenue, Boston, Massachusetts, 02115

Tel: +1-617-432-4565, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Scientific Director

Matthew E. Falagas
MD, MSc, DSc

- Director, Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
- Director, 1st Department of Internal Medicine, HYGEIA Hospital
- Adjunct Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts

View CV

Services

Travel Medicine

People who travel may be exposed to dangers, which might have an impact on their entertainment or business plans (traveler's diarrhea, jet lag, malaria, yellow…

Inpatient Care

We admit our patients to HYGEIA Hospital, a pioneering, private institute, which everyone can trust his/her health. If admission of a patient is required for…

Outpatient Care

24 hours/day, 365 days/year availability of scientific staff to help patients.Telephone (210-68.39.600 and 6946-100.000 for emergencies) for easy access to services. 1. Attendance in our…

Academic Activities

Research

Alfa HealthCare has defined as one of its primary goals a considerable contribution in the production of high quality bio-medical research in Greece ..

Education

High-quality education of our medical, scientific, and nursing staff as well as patient education are among our basic aims

Publications

Scientific articles produced recently from our group have been published after peer-review in important journals ..

Congress Organization

One of the goals of Alfa HealthCare is to contribute to the organization of high-quality bio-medical conferences, congresses, and seminars in Greece and abroad.

Congress Organisation

One of the goals of Alfa HealthCare is to contribute to the organization of high-quality bio-medical conferences in Greece and abroad

Research

In colaboration with AIBE we have many important research programs in the fields of pathology

Εducation

We invest in the education of our medical, scientific, and nursing staff as well as in new medicine methods.

About

Alfa HealthCare S.A. is a medical anonymous company founded in 2002 in Athens, Greece. Our first goal is to provide high quality medical care, in the fields of Internal Medicine and Infectious Diseases. We offer outpatient care, as well as, secondary and tertiary care at the hospital level. ...